$
Federal Contract Award
Glaxosmithkline, LLC
Department of Health and Human Services · March 31, 2026 · FY2026
75A50124F61010Set-aside not reportedNAICS 541714
Obligated
$7,790,728
Contract details
- Award ID
- CONT_AWD_75A50124F61010_7505_75A50122D00002_7505
- PIID
- 75A50124F61010
- Period of performance
- February 21, 2024 → May 21, 2027
- Place of performance
- DURHAM, NC, USA
- Set-aside
- Not reported
- Pricing type
- FIRM FIXED PRICE
- PSC
- AN14 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES
- NAICS
- 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Scope
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE STORAGE AND STABILITY FOR ANTIGENS AND ADJUVANTS FROM PRIOR CONTRACTS FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D000002 DURING BASE PERIOD YR. 3. PERIOD OF PERFORMANCE: FEBRUARY
Parent vehicle (IDV)
Glaxosmithkline, LLC
UEI FRHTPHMZMX47
This award was placed as a task/delivery order under a larger contract vehicle.
Awarding agency
Department of Health and Human Services →- Sub-agency
- Office of Assistant Secretary for Preparedness and Response
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funding agency
- Department of Health and Human Services
- Funding office
- BARDA - ASPR / DAAPPO / BARDA DCMA
See every contract Glaxosmithkline, LLC has won
Full contracting history, year-over-year trends, subaward graph, and recompete alerts.
View Glaxosmithkline, LLC profile →